The Geriatric Acute and Post-Acute Fall Prevention Intervention (GAPcare) II to Assess the Use of the Apple Watch in Older Emergency Department Patients With Falls: Protocol for a Mixed Methods Study.
The Geriatric Acute and Post-Acute Fall Prevention Intervention (GAPcare) II to Assess the Use of the Apple Watch in Older Emergency Department Patients With Falls: Protocol for a Mixed Methods Study.
复制标题
DOI：
10.2196/24455
复制
发表时间：
2021-04-01
影响因子：
1.7
通讯作者：
Goldberg EM
中科院分区：
文献类型：
--
作者：
Strauss DH;Davoodi NM;Healy M;Metts CL;Merchant RC;Banskota S;Goldberg EM
跌倒是老年人中的一个常见问题，会导致受伤、急诊科就诊和住院。Apple Watch可以检测跌倒，并提醒护理人员和临床医生需要帮助；该设备还可以用于客观收集步态、健康和跌倒的数据，作为临床试验的一部分。然而，人们对这种技术在老年ED患者中的易用性知之甚少，这是一个反复跌倒的高风险人群。这项研究的目标是老年急性和急性后预防跌倒干预(GAPcare)II，旨在检查Apple Watch Series 4与iPhone和我们的研究应用Rhode Island Fitest(RIFitTest)在寻求跌倒护理的老年ED患者中的可行性、可接受性和可用性。我们将对跌倒的老年ED患者(n=25)和他们的照顾者(n=5)进行现场测试，以确定他们是否可以(1)连续或(2)定期使用Apple Watch、iPhone和APP，在有或没有研究人员电话帮助的情况下，评估步态、健康和/或随着时间的推移而摔倒。在初次见面期间，参与者将接受Apple Watch、iPhone和我们的研究应用程序的培训。他们将收到一本图文并茂的培训手册，如果他们有关于研究方案或设备使用的问题，可以拨打电话。参与者将在研究期间在APP上完成调查以及认知和运动评估。在研究结束时，我们将通过半结构化访谈征求参与者的反馈意见。将使用框架矩阵分析对定性数据进行汇总。传感器和调查响应数据将使用描述性统计进行分析。招聘从2019年12月开始，由于新冠肺炎疫情，从2020年4月到2020年9月暂停招聘。学习招募将继续，直到30名参与者被录取。这项研究已经罗德岛医院机构审查委员会批准(批准1400781-16)。GAPcare II将深入了解Apple Watch、iPhone和RIFitTest应用程序在最有可能从这项技术中受益的人群中的可行性、可接受性和可用性：老年人反复跌倒的风险很高。未来，可穿戴设备可以作为预防跌倒干预措施的一部分，在受伤发生之前进行预防。ClinicalTrials.gov NCT04304495；https://clinicaltrials.gov/ct2/show/NCT04304495 dr1-10.2196/24455
Falls are a common problem among older adults that lead to injury, emergency department (ED) visits, and institutionalization. The Apple Watch can detect falls and alert caregivers and clinicians that help is needed; the device could also be used to objectively collect data on gait, fitness, and falls as part of clinical trials. However, little is known about the ease of use of this technology among older adult ED patients, a population at high risk of recurrent falls. The goal of this study—the Geriatric Acute and Post-Acute Fall Prevention Intervention (GAPcare) II—is to examine the feasibility, acceptability, and usability of the Apple Watch Series 4 paired with the iPhone and our research app Rhode Island FitTest (RIFitTest) among older adult ED patients seeking care for falls. We will conduct field-testing with older adult ED patients (n=25) who sustained a fall and their caregivers (n=5) to determine whether they can use the Apple Watch, iPhone, and app either (1) continuously or (2) periodically, with or without telephone assistance from the research staff, to assess gait, fitness, and/or falls over time. During the initial encounter, participants will receive training in the Apple Watch, iPhone, and our research app. They will receive an illustrated training manual and a number to call if they have questions about the research protocol or device usage. Participants will complete surveys and cognitive and motor assessments on the app during the study period. At the conclusion of the study, we will solicit participant feedback through semistructured interviews. Qualitative data will be summarized using framework matrix analyses. Sensor and survey response data will be analyzed using descriptive statistics. Recruitment began in December 2019 and was on pause from April 2020 until September 2020 due to the COVID-19 pandemic. Study recruitment will continue until 30 participants are enrolled. This study has been approved by the Rhode Island Hospital Institutional Review Board (approval 1400781-16). GAPcare II will provide insights into the feasibility, acceptability, and usability of the Apple Watch, iPhone, and the RIFitTest app in the population most likely to benefit from the technology: older adults at high risk of recurrent falls. In the future, wearables could be used as part of fall prevention interventions to prevent injury before it occurs. ClinicalTrials.gov NCT04304495; https://clinicaltrials.gov/ct2/show/NCT04304495 DERR1-10.2196/24455
登录
查看更多内容
影响因子：
3.7
作者：
Rimland JM;Abraha I;Dell'Aquila G;Cruz-Jentoft A;Soiza R;Gudmusson A;Petrovic M;O'Mahony D;Todd C;Cherubini A
通讯作者：
Cherubini A
影响因子：
3.1
作者：
Tiedemann, Anne;Sherrington, Catherine;Close, Jacqueline C. T.
通讯作者：
Close, Jacqueline C. T.
影响因子：
7.2
作者：
Tromp, AM;Pluijm, SMF;Lips, P
通讯作者：
Lips, P
影响因子：
5.7
作者：
Mitchell, Uchechi A.;Chebli, Perla G.;Muramatsu, Naoko
通讯作者：
Muramatsu, Naoko
影响因子：
4
作者：
Gale NK;Heath G;Cameron E;Rashid S;Redwood S
通讯作者：
Redwood S